Cerundolo V - Search Results

1

PLGA Nanoparticles Co-encapsulating NY-ESO-1 Peptides and IMM60 Induce Robust CD8 and CD4 T Cell and B Cell Responses.

Dölen Y, Gileadi U, Chen JL, Valente M, Creemers JHA, Van Dinther EAW, van Riessen NK, Jäger E, Hruby M, Cerundolo V, Diken M, Figdor CG, de Vries IJM. Dölen Y, et al. Among authors: cerundolo v. Front Immunol. 2021 Feb 25;12:641703. doi: 10.3389/fimmu.2021.641703. eCollection 2021. Front Immunol. 2021. PMID: 33717196 Free PMC article.

2

Short peptides assist the folding of free class I heavy chains in solution.

Elliott T, Cerundolo V, Townsend A. Elliott T, et al. Among authors: cerundolo v. Eur J Immunol. 1992 Dec;22(12):3121-5. doi: 10.1002/eji.1830221214. Eur J Immunol. 1992. PMID: 1280223

3

High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo.

Ogg GS, Rod Dunbar P, Romero P, Chen JL, Cerundolo V. Ogg GS, et al. Among authors: cerundolo v. J Exp Med. 1998 Sep 21;188(6):1203-8. doi: 10.1084/jem.188.6.1203. J Exp Med. 1998. PMID: 9743539 Free PMC article.

4

Cutting edge: rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanoma.

Dunbar PR, Chen JL, Chao D, Rust N, Teisserenc H, Ogg GS, Romero P, Weynants P, Cerundolo V. Dunbar PR, et al. Among authors: cerundolo v. J Immunol. 1999 Jun 15;162(12):6959-62. J Immunol. 1999. PMID: 10358133

5

IFN-gamma exposes a cryptic cytotoxic T lymphocyte epitope in HIV-1 reverse transcriptase.

Sewell AK, Price DA, Teisserenc H, Booth BL Jr, Gileadi U, Flavin FM, Trowsdale J, Phillips RE, Cerundolo V. Sewell AK, et al. Among authors: cerundolo v. J Immunol. 1999 Jun 15;162(12):7075-9. J Immunol. 1999. PMID: 10358150

6

Effect of epitope flanking residues on the presentation of N-terminal cytotoxic T lymphocyte epitopes.

Gileadi U, Gallimore A, Van der Bruggen P, Cerundolo V. Gileadi U, et al. Among authors: cerundolo v. Eur J Immunol. 1999 Jul;29(7):2213-22. doi: 10.1002/(SICI)1521-4141(199907)29:07<2213::AID-IMMU2213>3.0.CO;2-8. Eur J Immunol. 1999. PMID: 10427984 Free article.

7

Generation of an immunodominant CTL epitope is affected by proteasome subunit composition and stability of the antigenic protein.

Gileadi U, Moins-Teisserenc HT, Correa I, Booth BL Jr, Dunbar PR, Sewell AK, Trowsdale J, Phillips RE, Cerundolo V. Gileadi U, et al. Among authors: cerundolo v. J Immunol. 1999 Dec 1;163(11):6045-52. J Immunol. 1999. PMID: 10570292

8

Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.

Jäger E, Nagata Y, Gnjatic S, Wada H, Stockert E, Karbach J, Dunbar PR, Lee SY, Jungbluth A, Jäger D, Arand M, Ritter G, Cerundolo V, Dupont B, Chen YT, Old LJ, Knuth A. Jäger E, et al. Among authors: cerundolo v. Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4760-5. doi: 10.1073/pnas.97.9.4760. Proc Natl Acad Sci U S A. 2000. PMID: 10781081 Free PMC article.

9

Generation and purification of CD8+ melan-A-specific cytotoxic T lymphocytes for adoptive transfer in tumor immunotherapy.

Oelke M, Moehrle U, Chen JL, Behringer D, Cerundolo V, Lindemann A, Mackensen A. Oelke M, et al. Among authors: cerundolo v. Clin Cancer Res. 2000 May;6(5):1997-2005. Clin Cancer Res. 2000. PMID: 10815925

10

Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL.

Chen JL, Dunbar PR, Gileadi U, Jäger E, Gnjatic S, Nagata Y, Stockert E, Panicali DL, Chen YT, Knuth A, Old LJ, Cerundolo V. Chen JL, et al. Among authors: cerundolo v. J Immunol. 2000 Jul 15;165(2):948-55. doi: 10.4049/jimmunol.165.2.948. J Immunol. 2000. PMID: 10878370

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

320 results

Search Page